1 July 2000 in American Journal of Ophthalmology
2 May 2007 in British Journal of Ophthalmology
To determine the mortality within ten years of diagnosis of chronic open angle glaucoma and the visual field progression amongst survivors of a group of patients who were followed for 10 years. Of the 436 patients seen in a glaucoma case-finding clinic between July 1994 and December 1995 a diagnosis of chronic open angle glaucoma was made in 65. Ten years after diagnosis the outcome of the 57 patients who were treated at the Oxford Eye Hospital was determined. The causes of death were obtained from the general practitioner records and from the official death certificates. The probability of death was analysed using a Kaplan-Meier survival curve. The visual field of each eye of survivors was graded using a nine-stage severity scale. The visual outcome was analysed at the 10-year follow up visit. Seventeen patients (29.8%) died during the 10-year period, including nine from cardiovascular disease. The mean (SD) age at presentation of those that died was 76.4 years (9.7) compared with 69.5 years (10.9) for survivors (p = 0.029). Using a nine-stage grading system, 42 eyes (52.5%) did not deteriorate, 30 eyes (37.5%) deteriorated by one stage, seven eyes (8.75%) two stages and one eye (1.25%) three stages over the 10-year period. The average time to first deterioration by one stage was 8.51 years (CI 7.92 to 9.10). The mean (SD) intraocular pressure was 25.6 mmHg (5.8 mmHg) on presentation and 15.7 mmHg (3.0 mmHg) at the end of 10 years. Approximately two thirds of patients will still be under care 10 years after presentation. In older, white patients with glaucoma the overall goal of preventing visual handicap is achievable for most patients 10 years after diagnosis.
1 May 2008 in Journal of Cataract & Refractive Surgery
To assess the long-term effect of vitreous loss during phacoemulsification on intraocular pressure (IOP) control in glaucoma patients. Birmingham and Midland Eye Centre, City Hospital, Birmingham, United Kingdom. In this study, 26 glaucoma cases with vitreous loss during phacoemulsification were identified from operative room records. The cases were performed from January 1999 to December 2001. Minimum follow-up was 12 months. Postoperative IOP control in eyes with vitreous loss (Group 1) was assessed and compared with that in stable fellow eyes (Group 2), which served as controls. Another control group (Group 3) comprised patients with primary open-angle glaucoma who had successful phacoemulsification. Case notes of 22 patients from the same period fulfilled these criteria. The 3 groups were comparable in age, sex, laterality, ethnicity, mean IOP, and mean number of medications preoperatively. Twelve months after surgery, 43.2% in Group 1, 23.1% in Group 2 (P<.05) and 4.5% in Group 3 had significantly worse IOP; the differences between Group 1 and Groups 2 and 3 were statistically significant (P<.05). Intraocular pressure control was significantly better in Group 3 than in Group 2 (P<.05). Vitreous loss during cataract surgery in glaucoma patients adversely affected IOP control in the long term. Results suggest that uneventful cataract surgery in glaucoma patients improves IOP control.
1 March 2003 in European Journal of Ophthalmology
Strabismus fixus is a rare condition and usually is of convergent type in which one or both eyes are anchored in a position of extreme adduction. Convergent type strabismus fixus is considered to be a congenital disorder (1) and a part of congenital extraocular muscle fibrosis syndrome (1). Villasecca (2) and Martinez (4) described an acquired type of strabismus fixus. Hayashi et al (3) reported that progressive esotropia could develop into the acquired type of convergent strabismus fixus. There are very few reports of divergent strabismus fixus in the literature. It may or may not be accompanied by ptosis or generalized extraocular muscle fibrosis. In our report, a case of divergent type strabismus fixus is described and discussed.
30 December 2024 in INTERNATIONAL JOURNAL OF EXPERIMENTAL RESEARCH AND REVIEW
Classifying tumors from MRI scans is a key medical imaging and diagnosis task. Conventional feature-based methods and traditional machine learning algorithms are used for tumor classification, which limits their performance and generalization. A hybrid framework is implemented for the classification of brain tumors using MRIs. The framework contains three basic components, i.e., Feature Extraction, Feature Fusion, and Classification. The feature extraction module uses a convolutional neural network (CNN) to automatically extract high-level features from MRI images. The high-level features are combined with clinical and demographic features through a feature fusion module for better discriminative power. The Support vector machine (SVM) was employed to classify the fused features as class label tumors by a classification module. The proposed model obtained 90.67% accuracy, 94.67% precision, 83.82% recall and 83.71% f1-score. Experimental results demonstrate the superiority of our framework over those existing solutions and obtain exceptional accuracy rates compared to all other frequently operated models. This hybrid deep learning framework has promising performance for efficient and reproducible tumor classification within brain MRI scans.